Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Amy Scurlock

TitleProfessor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPeds Pediatrics, College of Medicine
DivisionPeds Allergy
Address ACH Research Institute
1120 Marshall Street
Mail Slot # 512-13
Little Rock AR 72202
Phone501-364-1060
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Amy M. Scurlock, M.D. is an Associate Professor of Pediatrics at the University of Arkansas for Medical Sciences and Arkansas Children's Hospital. Dr. Scurlock is also a researcher at Arkansas Children's Hospital Research Institute. Dr. Scurlock received her M.D. in 1998 from the University of Arkansas for Medical Sciences. She completed a residency in Pediatrics at UAMS/ACH in 2001 and served as Chief Resident until 2002. She completed her Allergy-Immunology Fellowship Training at Duke University Medical Center in Durham North Carolina in 2004. Dr. Scurlock joined the UAMS faculty in August 2004 as a member of the Division of Pediatric Allergy/Immunology within the Department of Pediatrics. Dr. Scurlock's clinical interests include allergic and immunologic diseases such as food allergy, atopic dermatitis, eosinophilic esophagitis and primary immunodeficiency. She also has interest in newborn screening and long-term follow-up for infants with SCID and T-cell lymphopenia. Her research interests are focused on evaluation of mucosal immune responses in models of food allergy and eosinophilic gastrointestinal disorders. Dr. Scurlock is a member of the American Academy of Allergy Asthma and Immunology (AAAAI), Society for Mucosal Immunology, Society for Pediatric Research, Clinical Immunology Society, and American Academy of Pediatrics. She is board certified in both Pediatrics and Allergy-Immunology. Some of the UAMS College of Medicine faculty members provide pediatric patient care at Arkansas Children's Hospital. In addition, a wide range of pediatric services are provided in more than 35 subspecialties around Arkansas in locations such as the Schmieding Developmental Center in Springdale and the James L. Dennis Developmental Center in Little Rock. To make an appointment at Arkansas Children's Hospital, please call 501-364-4000.


    Collapse Research 
    Collapse research activities and funding
    039081     (SCURLOCK, AMY M)Jul 1, 2020 - Jun 30, 2025
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator
    039154     (SCURLOCK, AMY M)Jul 1, 2020 - Jun 30, 2025
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator
    ACRI #039427     (SCURLOCK, AMY M)Jul 1, 2017 - Jun 30, 2018
    UAMS ACHRI Flow Through
    FARE Network
    Role: Principal Investigator
    ACRI#039427     (SCURLOCK, AMY M)Jul 1, 2017 - Jun 30, 2018
    UAMS ACHRI Flow Through
    FARE Network
    Role: Principal Investigator
    K08AI077932     (SCURLOCK, AMY M.)Dec 25, 2008 - Nov 30, 2013
    NIH
    Immunoregulatory Networks in Chlamydia Genital Tract Infection
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Jefferson AA, Davidson L, Scurlock AM, Stern J. Food Insecurity and Health Inequities in Food Allergy. Curr Allergy Asthma Rep. 2024 Feb 29. PMID: 38421593.
      View in: PubMed
    2. Wood RA, Togias A, Sicherer SH, Shreffler WG, Kim EH, Jones SM, Leung DYM, Vickery BP, Bird JA, Spergel JM, Iqbal A, Olsson J, Ligueros-Saylan M, Uddin A, Calatroni A, Huckabee CM, Rogers NH, Yovetich N, Dantzer J, Mudd K, Wang J, Groetch M, Pyle D, Keet CA, Kulis M, Sindher SB, Long A, Scurlock AM, Lanser BJ, Lee T, Parrish C, Brown-Whitehorn T, Spergel AKR, Veri M, Hamrah SD, Brittain E, Poyser J, Wheatley LM, Chinthrajah RS. Omalizumab for the Treatment of Multiple Food Allergies. N Engl J Med. 2024 Mar 07; 390(10):889-899. PMID: 38407394.
      View in: PubMed
    3. Jones SM, Anvari S, Coleman A, Pesek RD, Kloepfer KM, Perry TT, Jefferson AA, Doan D, Andres A, Doderer M, Hilbun A, Solomon R, Scurlock AM. Food insecurity and allergic diseases: A?call to collective action. J Allergy Clin Immunol. 2024 Feb; 153(2):359-367. PMID: 37926122.
      View in: PubMed
    4. Keet C, Sicherer SH, Bunyavanich S, Visness C, Fulkerson PC, Togias A, Davidson W, Perry S, Hamrah S, Calatroni A, Robinson K, Dunaway L, Davis CM, Anvari S, Leong-Kee SM, Hershey GK, DeFranco E, Devonshire A, Kim H, Joseph C, Davidson B, Strong NK, Tsuang AJ, Groetch M, Wang J, Dantzer J, Mudd K, Aina A, Shreffler W, Yuan Q, Simmons V, Leung DYM, Hui-Beckman J, Ramos JA, Chinthrajah S, Winn V, Sindher T, Jones SM, Manning NA, Scurlock AM, Kim E, Stuebe A, Gern JE, Singh AM, Krupp J, Wood RA. The SunBEAm birth cohort: Protocol design. J Allergy Clin Immunol Glob. 2023 Aug; 2(3). PMID: 37771674.
      View in: PubMed
    5. Scurlock AM, Brown E, Davis CM. Food insecurity in children and adults with food allergies. Ann Allergy Asthma Immunol. 2022 10; 129(4):424-429. PMID: 35987455.
      View in: PubMed
    6. Ciaccio C, Goldsobel AB, Anagnostou A, Beyer K, Casale TB, Deschildre A, Fern?ndez-Rivas M, Hourihane JO, Krawiec M, Lieberman J, Scurlock AM, Vickery BP, Smith A, Tilles SA, Adelman DC, Brown KR. Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials. Ann Allergy Asthma Immunol. 2022 Dec; 129(6):758-768.e4. PMID: 35973655.
      View in: PubMed
    7. Jones SM, Kim EH, Nadeau KC, Nowak-Wegrzyn A, Wood RA, Sampson HA, Scurlock AM, Chinthrajah S, Wang J, Pesek RD, Sindher SB, Kulis M, Johnson J, Spain K, Babineau DC, Chin H, Laurienzo-Panza J, Yan R, Larson D, Qin T, Whitehouse D, Sever ML, Sanda S, Plaut M, Wheatley LM, Burks AW. Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study. Lancet. 2022 01 22; 399(10322):359-371. PMID: 35065784.
      View in: PubMed
    8. Pongracic JA, Gagnon R, Sussman G, Siri D, Oriel RC, Brown-Whitehorn TF, Green TD, Campbell DE, Anvari S, Berger WE, Bird JA, Chan ES, Cheema A, Chinthrajah RS, Chong HJ, Dowling PJ, Fineman SM, Fleischer DM, Gonzalez-Reyes E, Kim EH, Lanser BJ, MacGinnitie A, Mehta H, Petroni D, Rupp N, Schneider LC, Scurlock AM, Sher LD, Shreffler WG, Sindher SB, Stillerman A, Wood R, Yang WH, Bois T, Sampson HA, B?gin P. Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results. J Allergy Clin Immunol Pract. 2022 07; 10(7):1864-1873.e10. PMID: 34848381.
      View in: PubMed
    9. Berin MC, Agashe C, Burks AW, Chiang D, Davidson WF, Dawson P, Grishin A, Henning AK, Jones SM, Kim EH, Leung DYM, Masilamani M, Scurlock AM, Sicherer SH, Wood RA, Sampson HA. Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohorts. J Allergy Clin Immunol. 2022 04; 149(4):1373-1382.e12. PMID: 34653515.
      View in: PubMed
    10. Nilsson C, Scurlock AM, Dellon ES, Brostoff JM, Pham T, Ryan R, Brown KR, Adelman DC, Aceves SS. Onset of eosinophilic esophagitis during a clinical trial program of oral immunotherapy for peanut allergy. J Allergy Clin Immunol Pract. 2021 12; 9(12):4496-4501. PMID: 34389504.
      View in: PubMed
    11. Aluri J, Bach A, Kaviany S, Chiquetto Paracatu L, Kitcharoensakkul M, Walkiewicz MA, Putnam CD, Shinawi M, Saucier N, Rizzi EM, Harmon MT, Keppel MP, Ritter M, Similuk M, Kulm E, Joyce M, de Jesus AA, Goldbach-Mansky R, Lee YS, Cella M, Kendall PL, Dinauer MC, Bednarski JJ, Bemrich-Stolz C, Canna SW, Abraham SM, Demczko MM, Powell J, Jones SM, Scurlock AM, De Ravin SS, Bleesing JJ, Connelly JA, Rao VK, Schuettpelz LG, Cooper MA. Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function. Blood. 2021 05 06; 137(18):2450-2462. PMID: 33512449.
      View in: PubMed
    12. Scurlock AM, Burks AW, Sicherer SH, Leung DYM, Kim EH, Henning AK, Dawson P, Lindblad RW, Berin MC, Cho CB, Davidson WF, Plaut M, Sampson HA, Wood RA, Jones SM. Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research. J Allergy Clin Immunol. 2021 03; 147(3):992-1003.e5. PMID: 33290772.
      View in: PubMed
    13. Fleischer DM, Chinthrajah S, Scurlock AM, Campbell DE, Green TD, Bee KJ, Peillon A, Ocheltree T, Sampson HA. An evaluation of factors influencing response to epicutaneous immunotherapy for peanut allergy in the PEPITES trial. Allergy Asthma Proc. 2020 09 01; 41(5):326-335. PMID: 32539908.
      View in: PubMed
    14. Kim EH, Perry TT, Wood RA, Leung DYM, Berin MC, Burks AW, Cho CB, Jones SM, Scurlock A, Sicherer SH, Henning AK, Dawson P, Lindblad RW, Plaut M, Sampson HA. Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy. J Allergy Clin Immunol. 2020 10; 146(4):851-862.e10. PMID: 32535135.
      View in: PubMed
    15. Kim EH, Jones SM, Burks AW, Wood RA, Sicherer SH, Leung DYM, Henning AK, Lindblad RW, Dawson P, Keet C, Scurlock AM, Plaut M, Sampson HA. A 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocol. J Allergy Clin Immunol. 2020 04; 145(4):1292-1295.e1. PMID: 31881232.
      View in: PubMed
    16. Do AN, Watson CT, Cohain AT, Griffin RS, Grishin A, Wood RA, Wesley Burks A, Jones SM, Scurlock A, Leung DYM, Sampson HA, Sicherer SH, Sharp AJ, Schadt EE, Bunyavanich S. Dual transcriptomic and epigenomic study of reaction severity in peanut-allergic children. J Allergy Clin Immunol. 2020 04; 145(4):1219-1230. PMID: 31838046.
      View in: PubMed
    17. Dilley MA, Rettiganti M, Christie L, O'Brien E, Patterson M, Weeks C, Aronson J, Scurlock AM, Perry TT, Pesek RD, Bell MC, Kennedy JL, Chandler P, Magee J, Simmons L, Chervinskiy SK, Casey P, Jones SM. Impact of food allergy on food insecurity and health literacy in a tertiary care pediatric allergy population. Pediatr Allergy Immunol. 2019 05; 30(3):363-369. PMID: 30672621.
      View in: PubMed
    18. Scurlock AM. Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy. Clin Rev Allergy Immunol. 2018 Oct; 55(2):139-152. PMID: 29656306.
      View in: PubMed
    19. Poston TB, O'Connell CM, Girardi J, Sullivan JE, Nagarajan UM, Marinov A, Scurlock AM, Darville T. T Cell-Independent Gamma Interferon and B Cells Cooperate To Prevent Mortality Associated with Disseminated Chlamydia muridarum Genital Tract Infection. Infect Immun. 2018 07; 86(7). PMID: 29661927.
      View in: PubMed
    20. Chiang SCC, Vergamini SM, Husami A, Neumeier L, Quinn K, Ellerhorst T, Sheppard L, Gifford C, Buchbinder D, Joshi A, Ifversen M, Kleiner GI, Bussel JB, Chandrakasan S, Pesek RD, Pozos TC, Rose MJ, Scurlock AM, Zhang K, Bryceson YT, Bleesing J, Marsh RA. Screening for Wiskott-Aldrich syndrome by flow cytometry. J Allergy Clin Immunol. 2018 07; 142(1):333-335.e8. PMID: 29729304.
      View in: PubMed
    21. Cranmer JM, Scurlock AM, Hale RB, Ward WL, Prodhan P, Weber JL, Casey PH, Jacobs RF. An Adaptable Pediatrics Faculty Mentoring Model. Pediatrics. 2018 05; 141(5). PMID: 29669752.
      View in: PubMed
    22. Scurlock AM, Jones SM. Advances in the approach to the patient with food allergy. J Allergy Clin Immunol. 2018 06; 141(6):2002-2014. PMID: 29524535.
      View in: PubMed
    23. Pesek RD, Rettiganti M, O'Brien E, Beckwith S, Daniel C, Luo C, Scurlock AM, Chandler P, Levy RA, Perry TT, Kennedy JL, Chervinskiy S, Vonlanthen M, Casteel H, Fiedorek SC, Gibbons T, Jones SM. Effects of allergen sensitization on response to therapy in children with eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2017 08; 119(2):177-183. PMID: 28676207.
      View in: PubMed
    24. Virkud YV, Burks AW, Steele PH, Edwards LJ, Berglund JP, Jones SM, Scurlock AM, Perry TT, Pesek RD, Vickery BP. Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy. J Allergy Clin Immunol. 2017 Mar; 139(3):882-888.e5. PMID: 27609653.
      View in: PubMed
    25. Jones SM, Burks AW, Keet C, Vickery BP, Scurlock AM, Wood RA, Liu AH, Sicherer SH, Henning AK, Lindblad RW, Dawson P, Berin C, Fleischer DM, Leung DYM, Plaut M, Sampson HA. Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy. J Allergy Clin Immunol. 2016 Apr; 137(4):1117-1127.e10. PMID: 26924470.
      View in: PubMed
    26. Song Y, Wang J, Leung N, Wang LX, Lisann L, Sicherer SH, Scurlock AM, Pesek R, Perry TT, Jones SM, Li XM. Correlations between basophil activation, allergen-specific IgE with outcome and severity of oral food challenges. Ann Allergy Asthma Immunol. 2015 Apr; 114(4):319-26. PMID: 25841330.
      View in: PubMed
    27. Burks AW, Wood RA, Jones SM, Sicherer SH, Fleischer DM, Scurlock AM, Vickery BP, Liu AH, Henning AK, Lindblad R, Dawson P, Plaut M, Sampson HA. Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial. J Allergy Clin Immunol. 2015 May; 135(5):1240-8.e1-3. PMID: 25656999.
      View in: PubMed
    28. Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, Perry TT, Pesek RD, Sheikh S, Virkud Y, Smith PB, Shamji MH, Durham SR, Jones SM, Burks AW. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol. 2014 Feb; 133(2):468-75. PMID: 24361082.
      View in: PubMed
    29. Frazer LC, Scurlock AM, Zurenski MA, Riley MM, Mintus M, Pociask DA, Sullivan JE, Andrews CW, Darville T. IL-23 induces IL-22 and IL-17 production in response to Chlamydia muridarum genital tract infection, but the absence of these cytokines does not influence disease pathogenesis. Am J Reprod Immunol. 2013 Dec; 70(6):472-84. PMID: 24238108.
      View in: PubMed
    30. Dilley MA, Jones SM, Perry TT, Scurlock AM, Brodie-Fowler M, Bufford JD, Pesek RD. Pneumococcal meningitis in a patient with IL-1 receptor-associated kinase-4 deficiency: a case of failed prophylaxis. J Allergy Clin Immunol Pract. 2013 Nov-Dec; 1(6):700-3. PMID: 24565725.
      View in: PubMed
    31. Kennedy JL, Jones SM, Porter N, White ML, Gephardt G, Hill T, Cantrell M, Nick TG, Melguizo M, Smith C, Boateng BA, Perry TT, Scurlock AM, Thompson TM. High-fidelity hybrid simulation of allergic emergencies demonstrates improved preparedness for office emergencies in pediatric allergy clinics. J Allergy Clin Immunol Pract. 2013 Nov-Dec; 1(6):608-17.e1-14. PMID: 24565708.
      View in: PubMed
    32. Woods JL, Scurlock AM, Hensel DJ. Pelvic inflammatory disease in the adolescent: understanding diagnosis and treatment as a health care provider. Pediatr Emerg Care. 2013 Jun; 29(6):720-5. PMID: 23714759.
      View in: PubMed
    33. Petitto J, Chervinskiy SK, Scurlock AM, Perry TT, Jones SM, Pesek RD. Successful clarithromycin desensitization in a macrolide-sensitive pediatric patient. J Allergy Clin Immunol Pract. 2013 May-Jun; 1(3):307-8. PMID: 24565493.
      View in: PubMed
    34. Chin SJ, Vickery BP, Kulis MD, Kim EH, Varshney P, Steele P, Kamilaris J, Hiegel AM, Carlisle SK, Smith PB, Scurlock AM, Jones SM, Burks AW. Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison. J Allergy Clin Immunol. 2013 Aug; 132(2):476-8.e2. PMID: 23534975.
      View in: PubMed
    35. Fleischer DM, Burks AW, Vickery BP, Scurlock AM, Wood RA, Jones SM, Sicherer SH, Liu AH, Stablein D, Henning AK, Mayer L, Lindblad R, Plaut M, Sampson HA. Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol. 2013 Jan; 131(1):119-27.e1-7. PMID: 23265698.
      View in: PubMed
    36. Scurlock AM, Scurlock A. Encyclopedia of medical immunology. Diagnostic Testing for Food Allergies. 2013.
    37. Pesek RD, Scurlock AM, Jones SM. Encyclopedia of Medical Immunology. Future treatment of food allergy. 2013.
    38. Vickery BP, Lin J, Kulis M, Fu Z, Steele PH, Jones SM, Scurlock AM, Gimenez G, Bardina L, Sampson HA, Burks AW. Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens. J Allergy Clin Immunol. 2013 Jan; 131(1):128-34.e1-3. PMID: 23199605.
      View in: PubMed
    39. Burks AW, Jones SM, Wood RA, Fleischer DM, Sicherer SH, Lindblad RW, Stablein D, Henning AK, Vickery BP, Liu AH, Scurlock AM, Shreffler WG, Plaut M, Sampson HA. Oral immunotherapy for treatment of egg allergy in children. N Engl J Med. 2012 Jul 19; 367(3):233-43. PMID: 22808958.
      View in: PubMed
    40. Bell MC, Stovall SH, Scurlock AM, Perry TT, Jones SM, Harik NS. Addressing antimicrobial resistance to treat children with atopic dermatitis in a tertiary pediatric allergy clinic. Clin Pediatr (Phila). 2012 Nov; 51(11):1025-9. PMID: 22514191.
      View in: PubMed
    41. Anvari S, Scurlock AM, Jones SM, Perry TT, Hall PH. Influenza vaccination can be safely administered to most egg-allergic patients. J Ark Med Soc. 2011 Nov; 108(6):103-4. PMID: 23252020.
      View in: PubMed
    42. Woods JL, Bailey SL, Hensel DJ, Scurlock AM. Cervicitis in adolescents: do clinicians understand diagnosis and treatment? J Pediatr Adolesc Gynecol. 2011 Dec; 24(6):359-64. PMID: 21872515.
      View in: PubMed
    43. Lacy HM, Bowlin AK, Hennings L, Scurlock AM, Nagarajan UM, Rank RG. Essential role for neutrophils in pathogenesis and adaptive immunity in Chlamydia caviae ocular infections. Infect Immun. 2011 May; 79(5):1889-97. PMID: 21402767.
      View in: PubMed
    44. Varshney P, Jones SM, Scurlock AM, Perry TT, Kemper A, Steele P, Hiegel A, Kamilaris J, Carlisle S, Yue X, Kulis M, Pons L, Vickery B, Burks AW. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol. 2011 Mar; 127(3):654-60. PMID: 21377034.
      View in: PubMed
    45. Vickery BP, Scurlock AM, Jones SM, Burks AW. Mechanisms of immune tolerance relevant to food allergy. J Allergy Clin Immunol. 2011 Mar; 127(3):576-84; quiz 585-6. PMID: 21277624.
      View in: PubMed
    46. O'Connell CM, AbdelRahman YM, Green E, Darville HK, Saira K, Smith B, Darville T, Scurlock AM, Meyer CR, Belland RJ. Toll-like receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. trachomatis but not by C. muridarum. Infect Immun. 2011 Mar; 79(3):1044-56. PMID: 21199910.
      View in: PubMed
    47. Varshney P, Jones SM, Scurlock AM, Perry TT, Kemper A, Steele P, Hiegel A, Kamilaris J, Carlisle S, Yue X, Kulis M, Pons L, Vickery B, Burks AW. A randomized controlled study of peanut oral immunotherapy (OIT): clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol. 2011; 127(3):654-660.
    48. Scurlock AM, Frazer LC, Andrews CW, O'Connell CM, Foote IP, Bailey SL, Chandra-Kuntal K, Kolls JK, Darville T. IL-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not required for macrophage influx or normal resolution of infection. Infect Immun. 2011; 79(3):1349-1362.
    49. O'Connell CM, Abdelrahman YM, Green E, Darville HK, Saira K, Smith B, Darville T, Scurlock AM, Meyer CR, Belland RJ. TLR2 activation by Chlamydia trachomatis is plasmid-dependent and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. trachomatis but not by C. muridarum. Infect Immun. 2011; 79(3):1044-1056.
    50. Scurlock AM, Frazer LC, Andrews CW, O'Connell CM, Foote IP, Bailey SL, Chandra-Kuntal K, Kolls JK, Darville T. Interleukin-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not required for macrophage influx or normal resolution of infection. Infect Immun. 2011 Mar; 79(3):1349-62. PMID: 21149587.
      View in: PubMed
    51. Scurlock AM, Jones SM. An update on immunotherapy for food allergy. Curr Opin Allergy Clin Immunol. 2010 Dec; 10(6):587-93. PMID: 20856110.
      View in: PubMed
    52. Chavez A, Mian A, Scurlock AM, Blackall D, Com G. Antibiotic hypersensitivity in CF: drug-induced life-threatening hemolytic anemia in a pediatric patient. J Cyst Fibros. 2010 Dec; 9(6):433-8. PMID: 20833594.
      View in: PubMed
    53. Varshney P, Steele PH, Vickery BP, Bird JA, Thyagarajan A, Scurlock AM, Perry TT, Jones SM, Burks AW. Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol. 2009 Dec; 124(6):1351-2. PMID: 19913285.
      View in: PubMed
    54. Jones SM, Pons L, Roberts JL, Scurlock AM, Perry TT, Kulis M, Shreffler WG, Steele P, Henry KA, Adair M, Francis JM, Durham S, Vickery BP, Zhong X, Burks AW. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol. 2009 Aug; 124(2):292-300, 300.e1-97. PMID: 19577283.
      View in: PubMed
    55. Tan C, Hsia RC, Shou H, Haggerty CL, Ness RB, Gaydos CA, Dean D, Scurlock AM, Wilson DP, Bavoil PM. Chlamydia trachomatis-infected patients display variable antibody profiles against the nine-member polymorphic membrane protein family. Infect Immun. 2009 Aug; 77(8):3218-26. PMID: 19487469.
      View in: PubMed
    56. Hofmann AM, Scurlock AM, Jones SM, Palmer KP, Lokhnygina Y, Steele PH, Kamilaris J, Burks AW. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol. 2009 Aug; 124(2):286-91, 291.e1-6. PMID: 19477496.
      View in: PubMed
    57. Scurlock AM, Burks AW, Jones SM. Oral immunotherapy for food allergy. Curr Allergy Asthma Rep. 2009 May; 9(3):186-93. PMID: 19348718.
      View in: PubMed
    58. Darville T, Chandra-Kuntal K, Frazer L, Scurlock AM, O'Connell CM. Lack of oviduct pathology in mice infected with TLR2-signaling deficient chlamydiae is associated with earlier resolution of oviduct inflammation and a decreased Th17 Response. 2009.
    59. Scurlock AM, O'Connell CM, Andrews CW, Foote IP, Chandra-Kuntal K, Darville T. T-helper 17 Responses following Chlamydia muridarum Genital Tract Infection. Chlamydia Basic Research Society Meeting. 2009.
    60. Short JA, Morris PK, Scurlock AM. Treatment of Polyarthritis with Etanercept in a Patient with X-linked Agammaglobulinemia. 361. 2008; J Invest Med.
    61. Chavaz A, Mian A, Scurlock AM, Com G. Piperacillin-induced, Life-threatening Hemolytic Anemia in a Patient with Cystic Fibrosis. Fellows' Complicated Case Conference. 2008.
    62. Pesek R, Perry TT, Scurlock AM, Jones SM, Hall RW, Palmer KP, Scurlock AM. An Infant with Partial DiGeorge Syndrome, CHARGE Association, and Congenital Microgastria. J Invest Med. 2008; 360.
    63. Haynes AD, Lal A, Scurlock AM, Jones SM, Palmer KP, Hall P, Perry TT. Prolonged Eosinophilia and Respiratory Failure Associated with Visceral Larvae Migrans. J Invest Med. 2008; 358.
    64. Kloepfer K, Perry TT, Scurlock AM, Palmer K, Jones SM. Use of Abatacept to treat immune thrombocytopenia to treat common variable immunodeficiency. J Invest Med. 2008; 406.
    65. Hofmann AM, Steele P, Kamilaris JS, Jones SM, Palmer KP, Perry TT, Scurlock AM, Althage KA, Burks AW. Safety of Peanut Oral Immunotherapy (OIT). J Allergy Clin Immunol. 2008; S137.
    66. Jordan TJ, Jones SM, Perry TT, Palmer KP, Lyle RE, Bleesing JJ, Scurlock Am. A preterm infant with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. J Invest Med. 2008; 406.
    67. Kennedy J, Perry T, Scurlock AM, Palmer K, Simmons L, Schellhase D, Jones SM. Association of steroid-dependent asthma, immunodeficiency and Cowden syndrome in a family cohort. J Invest Med. 2008; 406.
    68. Nash SD, Steele PH, Kamilaris JS, Pons L, Kulis MD, Lee LA, Scurlock AM, Palmer KP, Perry TT, Jones SM, Burks AW. Oral peanut immunotherapy for children with peanut allergy. J Allergy Clin Immunol. 2008; S136.
    69. Adair MA, Laubach SS, Steele P, Kamilaris J, Pons L, Kulia M, Scurlock AM, Jones SM, Burks AW. Mean wheal size from peanut prick skin test and IgE levels in peanut allergic patients receiving oral peanut immunotherapy. J Allergy Clin Immunol. 2008; S136.
    70. O'Connell CM, Ingalls RR, Andrews CW, Scurlock AM, Darville T. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J Immunol. 2007 Sep 15; 179(6):4027-34. PMID: 17785841.
      View in: PubMed
    71. Haynes A, Scurlock AM, Jones SM, Palmer KP, Hall P, Perry TT. Prolonged Eosinophilia and Respiratory Failure Associated with Visceral Larva Migrans. 2007.
    72. Nash SD, Steele PH, Kamilaris JS, Pons LA, Kulis M, Lee LA, Althage KA, Christie L, Scurlock AM, Jones SM. Oral Peanut Immunotherapy for Peanut Allergic Patients. J Allergy Clin Immunol. 2007; S255.
    73. Bailey AE, Bleesing JJH, Jones SM, Perry TT, Palmer KP, Nagarajan UM, Scurlock AM. Major Histocompatibility Complex Class II Deficiency in a Child with CD4 Lymphopenia, Hypogammaglobulinemia , Recurrent Pneumonia, and Enteroviral Meningitis. 2007.
    74. Scurlock AM, Sikes JD, Foote IP, Rank RG, Darville T. Regulatory T-lymphocyte Kinetics Following Genital Tract Infection with Chlamydia Muridarum. 2007.
    75. Bailey AE, Bleesing JJH, Jones SM, Perry TT, Nagarajan UM, Scurlock AM. Major Histocompatibility Complex Class II Deficiency in a Child with Panhypogammaglobulinemia and Lymphopenia. J Allergy Clin Immunol. 2007; S255.
    76. Bailey AE, Bleesing JJH, Jones SM, Perry TT, Nagarajan UM, Scurlock AM. Major histocompatibility complex case II deficiency in a child with CD4 lymphopenia, hypogammaglobulinemia, a recurrent pneumonia, and enteroviral meningitis. J Invest Med. 2007; S249.
    77. Jordan TJ, Jones SM, Perry TT, Palmer KP, Bleesing JJH, Lyle RE, Scurlock AM. Immunologic Profile of a Preterm Neonate with Immune Deficiency Polyendocrinopathy Enteropathy, X-linked (IPEX) Syndrome. 2007.
    78. Buchanan AD, Green TD, Jones SM, Scurlock AM, Christie L, Althage KA, Steele PH, Pons L, Helm RM, Lee LA, Burks AW. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol. 2007 Jan; 119(1):199-205. PMID: 17208602.
      View in: PubMed
    79. Jones SM, Scurlock AM. The impact of food allergy: the real "fear factor". Ann Allergy Asthma Immunol. 2006 Mar; 96(3):385-6. PMID: 16597070.
      View in: PubMed
    80. LeBras MH, Saccente SL, Saylors RL, Perry TT, Jones SM, Scurlock AM. Modified Desensitization Protocol Using Two Formulations of L-Aspariginase in a Pediatric Patient with Recurrent Acute Lymphoblastic Leukemia (ALL). J Allergy Clin Immunol. 2006; S230.
    81. Perry TT, Scurlock AM, Jones SM. Food Allergy: Comprehension, Treatment and Prevention. Clinical Manifestations of Food Allergic Disease. 2006.
    82. Scurlock AM, Lee LA, Burks AW. Food allergy in children. Immunol Allergy Clin North Am. 2005 May; 25(2):369-88, vii-viii. PMID: 15878461.
      View in: PubMed
    83. Buchanan AD, Jones SM, Christie L, Althage KA, Scurlock AM, Helm RM, Pons LA, Andrzejewski SS, Steele PH, Burks AW. Treatment of Egg Allergy in Children Through Oral Desensitization. J Allergy Clin Immunol. 2005; S167.
    84. Christie L, Althage KA, Burks AW, Scurlock AM, Perry TT, Buchanan AD, Helm RM, Pons LA, Andrzejewski SS, Steele PH, Jones SM. Threshold Dose for Egg Allergy During Egg Desensitization Procedure. J Allergy Clin Immunol. 2005; S168.
    85. Scurlock AM, Steele PH, Andrzejewski SS, Pons LA, Althage KA, Christie L, Carlisle SK, Buchanan AD, Jones SM, Burks AW. Safety of Oral Peanut Immunotherapy for Peanut Allergic Patients. J Allergy Clin Immunol. 2005; S246.
    86. Scurlock AM, Burks AW. Food Allergy in Adults. 2004.
    87. Scurlock AM, Burks AW. Peanut allergenicity. Ann Allergy Asthma Immunol. 2004 Nov; 93(5 Suppl 3):S12-8. PMID: 15562869.
      View in: PubMed
    88. Rosenzweig SD, Dorman SE, Uzel G, Shaw S, Scurlock A, Brown MR, Buckley RH, Holland SM. A novel mutation in IFN-gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states. J Immunol. 2004 Sep 15; 173(6):4000-8. PMID: 15356149.
      View in: PubMed
    89. Scurlock AM, Rosenzweig SD, Sajaroff EO, Martin PL, Holland SM, Buckley RH. Successful HLA-Identical Bone Marrow Transplantation in a Patient with Interferon-Upsilon Receptor 2 Deficiency and Disseminated Mycobacterium avium Complex Infection. J Allergy Clin Immunol. 2004.
    90. Scurlock AM, Burks AW. Atlas of Allergy and Clinical Immunology. Food Allergy. 2004.
    91. Scurlock AM, Shaw SG, Rosenzweig SD, Sajaroff EO, Holland SM, Buckley RH. Interferon- Upsilon Receptor-2 Deficiency Presenting with Cytomegalovirus Infection. J Allergy Clin Immunol. 2003.
    92. Fuhrman SC, Scurlock AM, Peloquin CA. Intravenous Moxifloxacin Pharmacokinetics in an Immunocompromised Infant with Disseminated Mycobacterium Avium Complex Infection. Pediatric Pharmacy Advocacy Group (PPAG). 2003.
    93. Scurlock AM, Althage KA, Christie L, Burks AW, Jones SM. Anaphylaxis after ingestion of gummy bears. J Allergy Clin Immunol. 2002 Dec; 110(6):936-7. PMID: 12464963.
      View in: PubMed
    94. Scurlock AM, Vargas PA, Feild CR, Wheeler JG, Simpson PM, Barrett KW, Flick EL, Jones SM. Asthma knowledge among Head Start staff. Am J Resp Crit Care Med. 2002.
    95. Scurlock AM, Vargas PA, Feild CR, Simpson PM, Wheeler JG, Barrett KW, Flick EL, Jones SM. Assessment of pediatric asthma awareness among head start staff. J Clin Invest. 2002.
    96. Scurlock AM, Althage KA, Christie L, Burks AW, Jones SM. Anaphylaxis Following Ingestion of Gummi Bears. J Allergy Clin Immunol. 2002.
    97. Scurlock AM, Bhutta AT, Heulitt MJ, Harville TO, Burks AW, Jones SM. Near-Fatal Pneumocystis Carinii pneumonia in a previously immunocompetent infant treated with high-dose corticosteroids. J Clin Invest. 2001; 97A.
    98. Scurlock AM, Bhutta AT, Heulitt MJ, Harville TO, Burks AW, Jones SM. Near-Fatal Pneumocystis Carinii pneumonia in a previously immunocompetent infant treated with high-dose corticosteroids. J Allergy Clin Immunol. 2001; S212.
    99. Kennedy, JL, Thompson, TM, Perry, TT, Scurlock, AM, Jones, SM. Medical training in common pediatric allergic emergencies using high fidelity patient simulation mannequins. J Allergy Clin Immunol. S48.
    100. Perry, TT, Scurlock, AM, Jones, SM, Tilford, JM. Economic and caregiver impacts of food allergy (FA): Analyses from the 2005-2006 National Survey of Children with Special Health Care Needs. J Allergy Clin Immunol. S113.
    101. Scurlock, AM, O'Connell, CM, Andrews, CW, Foote, IP, Darville, T. Responses to Chlamydia Genital Tract Infection. J Allergy Clin Immunol. S138.
    102. Darville, T, Chandra-Kuntal, K, Frazer, L, Scurlock, AM, O'Connell, CM. Lack of oviduct pathology in mice infected with TLR2-signaling deficient chlamydiae is associated with earlier resolution of oviduct inflammation and a decreased Th17 Response. Chlamydia Basic Research Society Meeting.
    103. Varshney, P, Jones, SM, Pons, L, Kulis, M, Steele, PH, Kemper, AR, Scurlock, AM, Perry, TT, Burks, AW. Oral immunotherapy (OIT) induces clinical tolerance in peanut-allergic children. J Allergy Clin Immunol. S174.
    104. Bird, JA, Scurlock, AM, Perry, TT, Jones, SM, Pons, LA, Kulis,MD, Burks, AW. Regulatory T-cell patterns and cytokine profiles suggest the development of tolerance in patients undergoing peanut oral immunotherapy (OIT). J Allergy Clin Immunol. S151.
    105. Jones, SM, Scurlock, AM, Pons, L, Kulis, M, Perry, TT, Steele, P, Kamilaris, J, Henry, KA, Burks, AW. Double-blind, placebo-controlled (DBPC) trial of oral immunotherapy (OIT) in peanut allergic children. J Allergy Clin Immunol. S211.
    106. Christie, L, Althage, KA, Scurlock, AM, Perry, TT, Pons, L, Steele, P, Kamilaris, J, Jones, SM, Burks, AW. Threshold dose for peanut allergy during peanut oral immunotherapy procedure in children. J Allergy Clin Immunol. S77.
    107. Scurlock, AM, Andrews, CW, O'Connell, CM, Foote, IP, Chandra-Kuntal, K, Darville, T. Genital Mucosal T-helper 17 Responses in Chlamydia Infection and Immunopathogenesis. Keystone Symposium.
    108. Freeman, CL, Scurlock, AM, Jones, SM, Perry, TT. Complications associated with toxocara canis infection in three pediatric patients. J Invest Med. 313-314.
    109. Scurlock, AM, O'Connell, CM, Andrews, CW, Foote, IP, Chandra-Kuntal, K, Darville, T. T-helper 17 Responses following Chlamydia muridarum Genital Tract Infection. Chlamydia Basic Research Society Meeting.
    110. Petitto J, Perry TT, Schaefer GB, Jones SM, Scurlock AM. Novel chromodomain helicase DNA binding protein 7 gene mutation associated with CHARGE and atypical complete Digeorge Syndromes. J Invest Med.
    111. Pesek, RD, Vargas, PA, Jones, SM, Scurlock, AM, McCracken, A, Perry, TT. Asthma prevalence and morbidity among urban and rural school children in Arkansas. J Allergy Clin Immunol. S210.
    112. Bell, MC, Perry, TT, Scurlock, AM, Jones, SM. X-linked agammaglobulinemia with isolated IgM deficiency. J Invest Med. 313.
    Scurlock's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (267) concept(s)
    _
    Co-Authors Expand Description
    See all (15) people
    _
    Similar People Expand Description
    See all (31) people
    _
    Same Department Expand Description
    Search Department